“…Highly fluorescent semiconductor nanocrystals, quantum dots (QDs), with their unique size-dependent physical and chemical properties have been suggested as ideal candidates for this purpose. − The immense number of immunolabeling studies already published demonstrates that QDs are on their way of becoming the preferred fluorescent imaging probes. ,− Their properties, such as broad tunable fluorescence emission spectra that range from ultraviolet (UV) to infrared (IR), high surface to volume ratios and large absorption coefficients across the whole optical spectrum, make them ideal candidates for biomedical imaging, and immunofluorescent staining, especially of fixed cells and tissues . For cancer biomarker detection, QDs should be surface functionalized with specific recognition molecules for target detection, − such as primary or secondary antibody (Ab), ,, streptavidin, , peptides, , proteins, ,, and oligonucleotides. ,, Two most common strategies for QDs’ surface functionalization with Ab involve either direct cross-linking reaction of carboxylic/amino surface groups of QDs with amino/sulfhydryl groups of Abs or an indirect interaction of streptavidin coated QDs with biotinylated Abs. , However, both approaches have their own shortcomings. Inherently, QD surface functionalization with conventional Abs (Figure A), also known as immunoglobulin G (IgG) molecules (molecular weight of around 150 kDa), results in the formation of large conjugates, which are not optimum if intracellular target detection is required and the process of bioconjugation can lead to denaturation of these IgG molecules rendering them inactive .…”